Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
Chidamide With Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Etoposide for
Peripheral T Cell Lymphoma Patients : a Prospective, Randomized Controlled, Open Label, Phase
II Clinical Trial
Phase:
Phase 2
Details
Lead Sponsor:
Peking University
Collaborators:
Jiangxi Provincial Cancer Hospital Peking University International Hospital Shandong Tumor Hospital